RVL Pharmaceuticals PLC
NASDAQ:RVLP
Income Statement
Earnings Waterfall
RVL Pharmaceuticals PLC
Revenue
|
36.9m
USD
|
Cost of Revenue
|
-9.3m
USD
|
Gross Profit
|
27.6m
USD
|
Operating Expenses
|
-70.2m
USD
|
Operating Income
|
-42.6m
USD
|
Other Expenses
|
-25.7m
USD
|
Net Income
|
-68.3m
USD
|
Income Statement
RVL Pharmaceuticals PLC
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue |
74
N/A
|
50
-32%
|
18
-63%
|
39
+111%
|
35
-10%
|
43
+22%
|
50
+16%
|
37
-25%
|
37
-1%
|
|
Gross Profit | ||||||||||
Cost of Revenue |
(20)
|
(20)
|
(4)
|
(6)
|
(7)
|
(8)
|
(9)
|
(10)
|
(9)
|
|
Gross Profit |
53
N/A
|
30
-44%
|
14
-52%
|
33
+135%
|
28
-15%
|
35
+23%
|
40
+16%
|
27
-32%
|
28
+0%
|
|
Operating Income | ||||||||||
Operating Expenses |
(110)
|
(113)
|
(112)
|
(118)
|
(95)
|
(89)
|
(83)
|
(91)
|
(70)
|
|
Selling, General & Administrative |
(97)
|
(100)
|
(103)
|
(110)
|
(91)
|
(85)
|
(79)
|
(71)
|
(67)
|
|
Research & Development |
(8)
|
(8)
|
(9)
|
(8)
|
(5)
|
(4)
|
(4)
|
(4)
|
(3)
|
|
Other Operating Expenses |
(5)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
(16)
|
0
|
|
Operating Income |
(57)
N/A
|
(83)
-47%
|
(98)
-18%
|
(85)
+14%
|
(67)
+21%
|
(55)
+18%
|
(43)
+22%
|
(64)
-49%
|
(43)
+33%
|
|
Pre-Tax Income | ||||||||||
Interest Income Expense |
(6)
|
(5)
|
(5)
|
(6)
|
(5)
|
(1)
|
(0)
|
(6)
|
(9)
|
|
Non-Reccuring Items |
(46)
|
(46)
|
3
|
(2)
|
(2)
|
(3)
|
(16)
|
0
|
(28)
|
|
Total Other Income |
(1)
|
(1)
|
4
|
5
|
9
|
5
|
8
|
13
|
11
|
|
Pre-Tax Income |
(109)
N/A
|
(135)
-24%
|
(95)
+29%
|
(88)
+7%
|
(65)
+27%
|
(53)
+18%
|
(52)
+2%
|
(56)
-9%
|
(69)
-22%
|
|
Net Income | ||||||||||
Tax Provision |
6
|
4
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
|
Income from Continuing Operations |
(103)
|
(131)
|
(96)
|
(89)
|
(65)
|
(53)
|
(52)
|
(56)
|
(68)
|
|
Net Income (Common) |
(100)
N/A
|
(110)
-9%
|
(75)
+32%
|
(72)
+4%
|
(57)
+21%
|
(53)
+6%
|
(52)
+3%
|
(56)
-9%
|
(68)
-21%
|
|
EPS (Diluted) |
-1.6
N/A
|
-1.74
-9%
|
-0.91
+48%
|
-0.85
+7%
|
-0.67
+21%
|
-0.57
+15%
|
-0.52
+9%
|
-0.56
-8%
|
-0.7
-25%
|